Literature DB >> 16945739

Asymptomatic patients with diabetes mellitus should be screened for coronary artery disease.

Frans J Th Wackers.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16945739     DOI： 10.1016/j.nuclcard.2006.06.129

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  23 in total

1.  Comparative ability of myocardial perfusion single-photon emission computed tomography to detect coronary artery disease in patients with and without diabetes mellitus.

Authors:  X Kang; D S Berman; H Lewin; R Miranda; J Erel; J D Friedman; A M Amanullah
Journal:  Am Heart J       Date:  1999-05       Impact factor: 4.749

2.  Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI)

Authors: 
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus.

Authors:  X Kang; D S Berman; H C Lewin; I Cohen; J D Friedman; G Germano; R Hachamovitch; L J Shaw
Journal:  Am Heart J       Date:  1999-12       Impact factor: 4.749

4.  Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease.

Authors:  Andrea De Lorenzo; Ronaldo S L Lima; Aristarco G Siqueira-Filho; Mauricio R Pantoja
Journal:  Am J Cardiol       Date:  2002-10-15       Impact factor: 2.778

5.  Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

6.  Silent myocardial ischemia in patients with diabetes: who to screen.

Authors:  B Janand-Delenne; B Savin; G Habib; M Bory; P Vague; V Lassmann-Vague
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

7.  Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing.

Authors:  A Penfornis; C Zimmermann; D Boumal; A Sabbah; N Meneveau; S Gaultier-Bourgeois; J P Bassand; Y Bernard
Journal:  Diabet Med       Date:  2001-11       Impact factor: 4.359

8.  Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.

Authors:  Todd D Miller; Navin Rajagopalan; David O Hodge; Robert L Frye; Raymond J Gibbons
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749

9.  Trends in prevalence of diabetes mellitus in patients with myocardial infarction and effect of diabetes on survival. The Minnesota Heart Survey.

Authors:  J M Sprafka; G L Burke; A R Folsom; P G McGovern; L P Hahn
Journal:  Diabetes Care       Date:  1991-07       Impact factor: 19.112

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more
  8 in total

Review 1.  Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review.

Authors:  Ajay Yerramasu; Shreenidhi Venuraju Maggae; Avijit Lahiri; Dhakshinamurthy Vijay Anand
Journal:  J Nucl Cardiol       Date:  2007-12-26       Impact factor: 5.952

2.  Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Gabriele Pelissero; Sebastiano Bruno Solerte; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Adriana Garzaniti; Andrea Giustina
Journal:  Intern Emerg Med       Date:  2011-02-05       Impact factor: 3.397

3.  Cardiovascular events in Japanese asymptomatic patients with type 2 diabetes: a 1-year interim report of a J-ACCESS 2 investigation using myocardial perfusion imaging.

Authors:  Kenichi Nakajima; Yoshimitsu Yamasaki; Hideo Kusuoka; Tohru Izumi; Atsunori Kashiwagi; Ryuzo Kawamori; Kazuaki Shimamoto; Nobuhiro Yamada; Tsunehiko Nishimura
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

4.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

Review 5.  Erectile dysfunction as a cardiovascular risk factor in patients with diabetes.

Authors:  Giorgio Gandaglia; Andrea Salonia; Niccolò Passoni; Piero Montorsi; Alberto Briganti; Francesco Montorsi
Journal:  Endocrine       Date:  2012-09-05       Impact factor: 3.633

6.  Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.

Authors:  Kenichi Nakajima; Yasuchika Takeishi; Shinro Matsuo; Yoshimitsu Yamasaki; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2012-11-30       Impact factor: 5.952

7.  Noninvasive assessment of the carotid and cerebrovascular atherosclerotic plaques by multidetector CT in type-2 diabetes mellitus patients with transient ischemic attack or stroke.

Authors:  Ci He; Ming Gu; Rui Jiang; Jian-Hao Li
Journal:  Diabetol Metab Syndr       Date:  2013-02-26       Impact factor: 3.320

Review 8.  Diabetes and Subclinical Coronary Atherosclerosis.

Authors:  Chang Hoon Lee; Seung Whan Lee; Seong Wook Park
Journal:  Diabetes Metab J       Date:  2018-10       Impact factor: 5.376
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.